Biotest AG

Biotest AGverified

BIESF

Price:

$32

Market Cap:

$1.40B

Biotest Aktiengesellschaft develops, manufactures, and sells biological medicines in Germany and internationally. It operates through Therapy, Plasma & Services, and Other segments. The company offers its products in hematology, clinical immunology, and intensive care medicine areas. Its products include Haemoctin and Vihuma for the treatment of haemophilia A acute therapy and prophylaxis; and Haemonine for haemophilia B acute therapy and prophylaxis. The company's products also comprise Cytotect CP biotest for cytomegalovirus infections; Fovepta for hepatitis B prophylaxis in neonates; Hepatect for prophylaxis of hepatitis B reinfection; Intratect and IgG Next Genration for primary immune a...[Read more]

Industry

Biotechnology

IPO Date

2014-01-09

Stock Exchange

OTC

Ticker

BIESF

The PE Ratio as of November 2025 (TTM) for Biotest AG (BIESF) is -44.44

According to Biotest AG’s latest financial reports and current stock price. The company's current PE Ratio is -44.44. This represents a change of 111.52% compared to the average of -21.01 of the last 4 quarters.

Biotest AG (BIESF) Historical PE Ratio (quarterly & annually)

How has BIESF PE Ratio performed in the past?

The mean historical PE Ratio of Biotest AG over the last ten years is -46.39. The current -44.44 PE Ratio has changed 9.48% with respect to the historical average. Over the past ten years (40 quarters), BIESF's PE Ratio was at its highest in in the December 2020 quarter at 679.98. The PE Ratio was at its lowest in in the March 2019 quarter at -184.25.

Quarterly (TTM)
Annual

Average

-46.39

Median

-17.83

Minimum

-225.67

Maximum

40.47

Biotest AG (BIESF) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Biotest AG PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 1.85%

Maximum Annual PE Ratio = 40.47

Minimum Annual Increase = -3472.43%

Minimum Annual PE Ratio = -225.67

Quarterly (TTM)
Annual
YearPE RatioChange
202440.47316.30%
20239.72-122.91%
2022-42.4476.17%
2021-24.09-31.97%
2020-35.41-79.48%
2019-172.60-3472.43%
20185.12-102.27%
2017-225.671.85%
2016-11.5756.62%
2015-7.39-111.44%

Biotest AG (BIESF) Average PE Ratio

How has BIESF PE Ratio performed in the past?

The current PE Ratio of Biotest AG (BIESF) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

3-year avg

2.58

5-year avg

-10.35

10-year avg

-46.39

Biotest AG (BIESF) PE Ratio vs. Peers

How is BIESF’s PE Ratio compared to its peers?

Biotest AG’s PE Ratio is less than Mithra Pharmaceuticals S.A. (-0.09), less than Nipro Corporation (24.30), less than Karo Pharma AB (publ) (0), less than Drägerwerk AG & Co. KGaA (12.80), less than CompuGroup Medical SE & Co. KGaA (43.42), less than Opthea Limited (-1.15), less than Biotage AB (publ) (44.78), less than CompuGroup Medical SE & Co. KGaA (43.42), less than MorphoSys AG (-11.77), less than Oxurion N.V. (0.04),

Build a custom stock screener for Biotest AG (BIESF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Biotest AG using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Biotest AG (BIESF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Biotest AG or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Biotest AG's PE Ratio?

How is the PE Ratio calculated for Biotest AG (BIESF)?

What is the highest PE Ratio for Biotest AG (BIESF)?

What is the 3-year average PE Ratio for Biotest AG (BIESF)?

What is the 5-year average PE Ratio for Biotest AG (BIESF)?

How does the current PE Ratio for Biotest AG (BIESF) compare to its historical average?